Robert M Pollack

US Patent:

8516116, Aug 20, 2013

Filed:

Nov 30, 2006

Appl. No.:

11/565378

Inventors:

Robert H. Pollack - Philadelphia PA, US

Assignee:

Accenture Global Services Limited - Dublin

International Classification:

G06F 15/173
G06F 15/16

US Classification:

709225, 709203, 709224, 709226, 709228, 709229

Abstract:

Context-based routing of requests in a service-oriented architecture (SOA) is achieved by using context information received from service providers to make routing decisions. Service providers publish information about their context on a publish-and-subscribe channel. A router (e. g. , a JBI normalized message router) subscribes to the channel to receive the context information, and may store the context information in a context repository. A consumer issues a service request specifying a context, and the router uses the context information received from the service providers to select the service provider that best satisfies the context. The request is then routed to the selected service provider.

US Patent:

20060075391, Apr 6, 2006

Filed:

Oct 5, 2004

Appl. No.:

10/958561

Inventors:

Laurence Esmonde - West Chester PA, US
Michael Horton - Ambler PA, US
Bryan Hunter - Collegeville PA, US
Mark Kilby - Altamonte Springs FL, US
John Neyer - Harleysville PA, US
David Perme - Wayne PA, US
Robert Pollack - Philadelphia PA, US
James Solderitsch - Rosemont PA, US
Peter Solderitsch - Havertown PA, US
Bryan Tedesco - Downington PA, US

International Classification:

G06F 9/45

US Classification:

717136000

Abstract:

A Scenario Generation Framework is described. The Framework provides the organizational infrastructure through which scenario data—a shared set of data supporting enterprise application coordination and interoperation—can effectively be managed from a centralized location. From this location, the framework provides capabilities whereby scenario data, described using a published data representation format, can be copied, viewed, formally compared, modified and combined with other segments of scenario data. Also from this location, suitably transformed data can be communicated to applications for use in initializing their execution in concert with other applications. In the preferred embodiment of the framework, workflow management capabilities are included to allow distribution and control of data preparation activities and an integrated workstation is made available to facilitate data manipulation and modification.

US Patent:

20060106226, May 18, 2006

Filed:

Jan 11, 2006

Appl. No.:

11/330572

Inventors:

Robert Pollack - Philadelphia PA, US
John Godfrey - Huntingdon Valley PA, US
Sharon Gaglia - Veneta OR, US

International Classification:

C07C 227/40
C07D 233/61
C07D 209/20

US Classification:

548498000, 562443000, 562444000, 548335500

Abstract:

Embodiments of the present invention provide processes for extracting amino acids from mixtures of amino acids, and compositions and mixtures formed therefrom. Applications include separating and/or isolating non-aromatic amino acids, and/or separating aromatic amino acids into at least one fraction containing phenylalanine and tyrosine and a fraction containing L-β-3-indolylalanine (L-β-3) and providing natural or other amino acid mixtures thereof. The source of amino acids may include a natural source, such as an enzymaticaly hydrolyzed protein or other natural protein hydrolysates containing mixtures of free amino acids. The processes of embodiments of the present invention include contacting the mixture of amino acids with a resin or hydrophobic substance that is attractive to aromatic amino acids but not attractive to aliphatic amino acids to separate the aromatic amino acids from the rest of the mixture.

US Patent:

20070161784, Jul 12, 2007

Filed:

Jan 11, 2006

Appl. No.:

11/330573

Inventors:

Robert Pollack - Philadelphia PA, US
Sharon Gaglia - Veneta OR, US

International Classification:

C07K 1/12
C07C 229/02

US Classification:

530414000, 562553000

Abstract:

Embodiments of the present invention provide processes for extracting amino acids from mixtures of amino acids, and compositions and mixtures formed therefrom. Applications include separating and/or isolating non-aromatic amino acids, and/or separating aromatic amino acids into at least one fraction containing phenylalanine and tryrosine and a fraction containing L-β-3-indolylalanine (L-β-3) and providing natural or other amino acid mixtures thereof. The source of amino acids may include a natural source, such as an enzymatically hydrolyzed protein or other natural protein hydrolysates containing mixtures of free amino acids. The processes of embodiments of the present invention include contacting the mixture of amino acids with a resin or hydrophobic substance that is attractive to aromatic amino acids but not attractive to aliphatic amino acids to separate the aromatic amino acids from the rest of the mixture.

US Patent:

46507892, Mar 17, 1987

Filed:

Oct 15, 1985

Appl. No.:

6/787502

Inventors:

Robert L. Pollack - Philadelphia PA

Assignee:

Commonwealth Medical Corporation of America - Allentown PA

International Classification:

A61K 3140
A61K 3144
A61K 3162
A61K 3170
A61K 31435

US Classification:

514 23

Abstract:

The production of the neurotransmitter serotonin is increased through administration of a therapeutic composition which includes L-tryptophan in combination with a salicylate, pyridoxine, niacin and a carbohydrate such as fructose. Both the absolute free fraction and the relative amount of the albumin-bound fraction of serum L-tryptophan are increased so that transport of L-tryptophan from the blood plasma across the blood-brain barrier into the brain is increased. Once within the brain, L-tryptophan is converted to serotonin.

US Patent:

48533777, Aug 1, 1989

Filed:

Feb 29, 1988

Appl. No.:

7/165444

Inventors:

Robert L. Pollack - Philadelphia PA

International Classification:

A61K 3135
A61K 3140
A61K 3162
A61K 3170

US Classification:

514161

Abstract:

The production of the neurotransmitter serotonin is increased through administration of a therapeutic composition which includes L-tryptophan in combination with a salicylate, an ascorbate, calcium, magnesium, copper, pyridoxine, niacin and a carbohydrate such as fructose. Both the absolute free fraction and the relative amount of the albumin-bound fraction of serum L-tryptophan are increased so that transport of L-tryptophan from the blood plasma across the blood-brain barrier into the brain is increased. Once within the brain, L-tryptophan is converted to serotonin.

US Patent:

46394656, Jan 27, 1987

Filed:

Aug 30, 1985

Appl. No.:

6/771325

Inventors:

Robert L. Pollack - Philadelphia PA
Lawrence Durst - Bridgeport PA

Assignee:

Commonwealth Medical Corporation of America - Allentown PA

International Classification:

A61K 3140
A61K 3170
A61K 31435

US Classification:

514419

Abstract:

Intractable chronic pain is eliminated or relieved through administration of a composition including L-tryptophan in combination with fructose, pyridoxine and niacinamide. Each ingredient either promotes the transport of L-tryptophan from the blood plasma across the blood-brain barrier into the brain or promotes the conversion of L-tryptophan within the brain to the neurotransmitter serotonin.

US Patent:

48973807, Jan 30, 1990

Filed:

Jan 27, 1987

Appl. No.:

7/007121

Inventors:

Robert L. Pollack - Philadelphia PA
Lawrence Durst - Bridgeport PA

International Classification:

A61K 3140
A61K 3170
A61K 31435

US Classification:

514 23

Abstract:

A composition for treating physiological disorders responsive to treatment with the neurotransmitter serotonin includes L-tryptophan, fructose, niacinamide, pyridoxine, calcium ascorbate, copper gluconate and magnesium oxide. Each ingredient either promotes the transport of L-tryptophan from the blood plasma across the blood-brain barrier into the brain, or promotes the synthesis of serotonin from L-tryptophan.